Human Herpes Simplex Virus: Life Cycle and Development of Inhibitors

被引：123

作者：

Kukhanova, M. K. ^{[1
]}

Korovina, A. N. ^{[1
]}

Kochetkov, S. N. ^{[1
]}

机构：

[1] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 119991, Russia

来源：

BIOCHEMISTRY-MOSCOW | 2014年 / 79卷 / 13期

基金：

俄罗斯基础研究基金会;

关键词：

HSV; herpes simplex; life cycle; replication; drugs; mutations; resistance; TYPE-1; DNA-POLYMERASE; HELICASE-PRIMASE INHIBITORS; NUCLEAR-LOCALIZATION SIGNAL; GUINEA-PIG MODEL; THYMIDINE KINASE; VIRAL REPLICATION; C-TERMINUS; IN-VITRO; HERPES-SIMPLEX-VIRUS-1; DNA; ANTIHERPESVIRUS ACTIVITY;

D O I：

10.1134/S0006297914130124

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

WHO reports that 90% of human population is infected by different types of herpesviruses, which develop latency or cause oral and genital herpes, conjunctivitis, eczema herpeticum, and other diseases. Herpesvirus almost always accompanies HIV-infection and complicates AIDS treatment. Herpes simplex virus type 1 is one of the most wide spread viruses from the Herpesviridae family. HSV virion, genome structure, replication mechanisms, antiherpes drug development strategies, including design of prodrugs, and mutations causing ACV-resistance in clinical HSV isolates are discussed in this review.

引用

页码：1635 / 1652

页数：18

共 109 条

[21] THE IMPLICATIONS OF RESISTANCE TO ANTIVIRAL AGENTS FOR HERPESVIRUS DRUG TARGETS AND DRUG-THERAPY [J].

COEN, DM .

ANTIVIRAL RESEARCH, 1991, 15 (04) :287-300

[22] Antiherpesvirus drugs: A promising spectrum of new drugs and drug targets [J].

Coen, DM ;

Schaffer, PA .

NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (04) :278-288

[23] Herpes Simplex Virus Replication: Roles of Viral Proteins and Nucleoporins in Capsid-Nucleus Attachment [J].

Copeland, Anna Maria ;

Newcomb, William W. ;

Brown, Jay C. .

JOURNAL OF VIROLOGY, 2009, 83 (04) :1660-1668

[24] Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease [J].

Crute, JJ ;

Grygon, CA ;

Hargrave, KD ;

Simoneau, B ;

Faucher, AM ;

Bolger, G ;

Kibler, P ;

Liuzzi, M ;

Cordingley, MG .

NATURE MEDICINE, 2002, 8 (04) :386-391

[25]

CRUTE JJ, 1989, J BIOL CHEM, V264, P19266

[26] Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy [J].

De Clercq, E ;

Field, HJ .

BRITISH JOURNAL OF PHARMACOLOGY, 2006, 147 (01) :1-11

[27] Acyclic/carbocyclic guanosine analogues as anti-herpesvirus agents [J].

De Clercq, E ;

Andrei, G ;

Snoeck, R ;

De Bolle, L ;

Naesens, L ;

Degrève, B ;

Balzarini, J ;

Zhang, Y ;

Schols, D ;

Leyssen, P ;

Ying, C ;

Neyts, J .

NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2001, 20 (4-7) :271-285

[28] 1,2,4-Triazoloazine derivatives as a new type of herpes simplex virus inhibitors [J].

Deev, S. L. ;

Yasko, M. V. ;

Karpenko, I. L. ;

Korovina, A. N. ;

Khandazhinskaya, A. L. ;

Andronova, V. L. ;

Galegov, G. A. ;

Shestakova, T. S. ;

Ulomskii, E. N. ;

Rusinov, V. L. ;

Chupakhin, O. N. ;

Kukhanova, M. K. .

BIOORGANIC CHEMISTRY, 2010, 38 (4-6) :265-270

[29] DURING LATENCY, HERPES-SIMPLEX VIRUS TYPE-1 DNA IS ASSOCIATED WITH NUCLEOSOMES IN A CHROMATIN STRUCTURE [J].

DESHMANE, SL ;

FRASER, NW .

JOURNAL OF VIROLOGY, 1989, 63 (02) :943-947

[30] THE EXTREME-C TERMINUS OF HERPES-SIMPLEX VIRUS-DNA POLYMERASE IS CRUCIAL FOR FUNCTIONAL INTERACTION WITH PROCESSIVITY FACTOR-UL42 AND FOR VIRAL REPLICATION [J].

DIGARD, P ;

BEBRIN, WR ;

WEISSHART, K ;

COEN, DM .

JOURNAL OF VIROLOGY, 1993, 67 (01) :398-406

← 1 2 3 4 5 6 7 8 9 10 →